Gaingels

Activity from announced rounds

Activity in this selectionSeries B

Gaingels co-invests alongside venture leads in companies committed to diverse and inclusive teams, spanning seed through growth and pre-IPO rounds across technology, healthcare and consumer markets.

Its investor community includes LGBTQ+ people and allies, extending representation within the ownership of venture-backed companies. Portfolio companies work with its Gaingels Letter commitments and Venture Inclusion programme on building more inclusive organisations.

A board access programme provides free recruitment advice for diverse board members and observers. This gives founders a practical governance resource alongside a co-investment partner for a round led by another venture firm.

Sources
Rounds participated in
6
Confirmed lead rounds
0
3 roles undisclosed
New companies
6
First participation on record · 0 follow-on
Funding in participating rounds
$295M
6 disclosed · full round size, not this investor’s share

By stage

Series B6

By primary sector

Fintech2
Biotech1
Enterprise software1
Healthtech1
Industrial tech1

By country

United States5
1

Rounds

6 in this selection
North.cloud

Cloud spending software that helps engineering and finance teams allocate costs and automate infrastructure savings.

$60MSeries B
Participant
Tiny Health

Tiny Health provides gut and vaginal microbiome testing and analysis to help families understand microbiome health across life stages.

$33MSeries B
Participant
Superluminal Medicines

Superluminal Medicines combines structural biology, protein dynamics, machine learning and experimental testing to discover small-molecule drugs for difficult G protein-coupled receptor targets. Its pipeline focuses on endocrine and cardiometabolic diseases, including rare genetic and hypothalamic obesity.

$60MSeries B
Participant
Standard Metrics

AI-driven portfolio management platform for VC and private equity firms

$20MSeries B
Role not disclosed
RenoFi

Provides AI-enabled renovation financing platform for homeowners

$22MSeries B
Role not disclosed
Cambium

Cambium develops advanced materials for defense, aerospace and other high-performance applications using AI.

$100MSeries B
Role not disclosed